Filing Details
- Accession Number:
- 0001209191-20-029186
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2020-05-14 16:19:24
- Reporting Period:
- 2020-05-12
- Accepted Time:
- 2020-05-14 16:19:24
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 875320 | Vertex Pharmaceuticals Inc / Ma | VRTX | Pharmaceutical Preparations (2834) | 043039129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1242825 | M Jeffrey Leiden | C/O Vertex Pharmaceuticals Incorporated 50 Northern Avenue Boston MA 02210 | Executive Chairman | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2020-05-12 | 24,215 | $187.53 | 65,036 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-12 | 35,499 | $96.87 | 100,535 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-12 | 4,470 | $91.05 | 105,005 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2020-05-12 | 24,348 | $155.57 | 129,353 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2020-05-12 | 9,015 | $277.14 | 120,338 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 4,428 | $277.94 | 115,910 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 1,940 | $278.96 | 113,970 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 6,498 | $280.76 | 107,472 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 9,398 | $281.83 | 98,074 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 9,780 | $282.66 | 88,294 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 9,219 | $283.86 | 79,075 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 10,179 | $285.06 | 68,896 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 8,391 | $285.68 | 60,505 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 15,792 | $286.70 | 44,713 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 9,630 | $287.81 | 35,083 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2020-05-12 | 100 | $288.42 | 34,983 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-12 | 24,215 | $0.00 | 24,215 | $187.53 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-12 | 35,499 | $0.00 | 35,499 | $96.87 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-12 | 4,470 | $0.00 | 4,470 | $91.05 |
| Common Stock | Stock Option (Right to Buy) | Disposition | 2020-05-12 | 24,348 | $0.00 | 24,348 | $155.57 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2029-02-05 | No | 4 | M | Direct | |
| 0 | 2024-07-14 | No | 4 | M | Direct | |
| 93,866 | 2026-02-01 | No | 4 | M | Direct | |
| 0 | 2028-02-05 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 440 | Indirect | 401(k) |
Footnotes
- Transaction made pursuant to Dr. Leiden's company approved trading plan under Rule 10b5-1.
- Open market sales reported on this line occurred at a weighted average price of $277.14 (range $276.63 to $277.61).
- Dr. Leiden undertakes to provide (upon request by the SEC staff, the issuer or a security holder of the issuer) full information regarding the number of shares sold at each separate price.
- Open market sales reported on this line occurred at a weighted average price of $277.94 (range $277.63 to $278.41).
- Open market sales reported on this line occurred at a weighted average price of $278.96 (range $278.71 to $279.10).
- Open market sales reported on this line occurred at a weighted average price of $280.76 (range $280.17 to $281.13).
- Open market sales reported on this line occurred at a weighted average price of $281.83 (range $281.29 to $282.24).
- Open market sales reported on this line occurred at a weighted average price of $282.66 (range $282.33 to $283.28).
- Open market sales reported on this line occurred at a weighted average price of $283.86 (range $283.35 to $284.30).
- Open market sales reported on this line occurred at a weighted average price of $285.06 (range $284.36 to $285.35).
- Open market sales reported on this line occurred at a weighted average price of $285.68 (range $285.36 to $286.35).
- Open market sales reported on this line occurred at a weighted average price of $286.70 (range $286.37 to $287.31).
- Open market sales reported on this line occurred at a weighted average price of $287.81 (range $287.37 to $288.27).
- Fully vested.
Billionaire Hedge Funds
